Literature DB >> 10820527

Relation between natural killer cells and neoplastic cells in serous fluids.

J A Laurini1, A Garcia, B Elsner, M Bellotti, C Rescia.   

Abstract

Natural killer (NK) cells are capable of lysing certain tumor cells in vitro. We investigated whether the percentage of NK cells (NK%) in serous effusions has any relation with the presence of malignant cells. Fresh effusions were routinely processed, and a portion of them was submitted for lymphocyte immunophenotyping, using a flow cytometer. Fifty-one fluids (15 peritoneal, 36 pleural), from 47 patients were analyzed. Thirty-two cases were negative and 19 were positive for neoplastic cells: there were 13 adenocarcinomas, 2 malignant mesotheliomas (MM), 3 malignant lymphomas (ML), and 1 rhabdomyosarcoma (R). Negative cases showed an average NK% of 5.09% (1-16%). Effusions positive for adenocarcinoma had an average NK% of 22.08% (12-33%) (P < 0.001). MM, ML, and R had a low NK%, with an average of 3.01% (0-5%). Investigation of the NK% could be useful in cytologically doubtful cases and in the differential diagnosis between MM and adenocarcinoma. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2000        PMID: 10820527     DOI: 10.1002/(sici)1097-0339(200006)22:6<347::aid-dc4>3.0.co;2-t

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  Cytotoxic Natural Killer Subpopulations as a Prognostic Factor of Malignant Pleural Effusion.

Authors:  Susana Herrera Lara; Estrella Fernández-Fabrellas; Gustavo Juan Samper; Josefa Marco Buades; Rafael Andreu Lapiedra; Amparo Pinilla Moreno; María Morales Suárez-Varela
Journal:  Lung       Date:  2018-12-06       Impact factor: 2.584

Review 2.  Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.

Authors:  S K Mohanty; P Dey
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

Review 3.  Flow cytometry, molecular analysis, and other special techniques (in Serous Fluid Cytopathology).

Authors:  Ali Gabali
Journal:  Cytojournal       Date:  2022-03-19       Impact factor: 2.345

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.